InsidersTradesSigma
Track the 인벤티지랩 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 인벤티지랩 has published 67 reports. The latest transaction was reported on 29 June 2026 (Purchase). Among the most active insiders: 류충호. The full history is free.
67
Insider Decl.
n/a
Thresholds
n/a
33 ops.
Buy Volume
n/a
13 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 June 2026
Declarations67 total
117,874 sharesKRXDART:20260107000527
25 of 67 declarations
Acerca de 인벤티지랩
InvenTige Lab es una empresa del sector de la salud y farmacéutico, cotizada en el XKRX. Se centra en el desarrollo de soluciones innovadoras para mejorar la atención médica.